Similar articles for PMID: 11352694

Year	Number of Results
1955	1
1961	1
1981	1
1982	1
1984	1
1986	1
1988	2
1989	6
1990	2
1991	6
1992	5
1993	7
1994	2
1995	22
1996	17
1997	14
1998	22
1999	27
2000	22
2001	25
2002	28
2003	22
2004	15
2005	10
2006	5
2007	8
2008	14
2009	12
2010	3
2011	7
2012	4
2013	16
2014	7
2015	4
2016	4
2017	5
2018	9
2019	11
2020	5
2021	3
2022	3
2023	3
2024	2

1

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A. Hunt D, et al. Ann Intern Med. 2001 May 15;134(10):931-40. doi: 10.7326/0003-4819-134-10-200105150-00007. Ann Intern Med. 2001. PMID: 11352694 Clinical Trial.

2

Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators. Hague W, et al. Am Heart J. 2003 Apr;145(4):643-51. doi: 10.1067/mhj.2003.1. Am Heart J. 2003. PMID: 12679760 Clinical Trial.

3

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease). LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease). Lancet. 2002 Apr 20;359(9315):1379-87. doi: 10.1016/S0140-6736(02)08351-4. Lancet. 2002. PMID: 11978335 Clinical Trial.

4

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E. Lewis SJ, et al. Ann Intern Med. 1998 Nov 1;129(9):681-9. doi: 10.7326/0003-4819-129-9-199811010-00002. Ann Intern Med. 1998. PMID: 9841599 Clinical Trial.

5

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002 Dec 18;288(23):2998-3007. doi: 10.1001/jama.288.23.2998. JAMA. 2002. PMID: 12479764 Clinical Trial.

6

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998 Nov 5;339(19):1349-57. doi: 10.1056/NEJM199811053391902. N Engl J Med. 1998. PMID: 9841303 Free article. Clinical Trial.

7

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.

Sacks FM, Tonkin AM, Shepherd J, Braunwald E, Cobbe S, Hawkins CM, Keech A, Packard C, Simes J, Byington R, Furberg CD. Sacks FM, et al. Circulation. 2000 Oct 17;102(16):1893-900. doi: 10.1161/01.cir.102.16.1893. Circulation. 2000. PMID: 11034935 Clinical Trial.

8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Shepherd J, et al. N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001. N Engl J Med. 1995. PMID: 7566020 Free article. Clinical Trial.

9

Long-term follow-up of the West of Scotland Coronary Prevention Study.

Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM; West of Scotland Coronary Prevention Study Group. Ford I, et al. N Engl J Med. 2007 Oct 11;357(15):1477-86. doi: 10.1056/NEJMoa065994. N Engl J Med. 2007. PMID: 17928595 Free article. Clinical Trial.

10

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.

Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK. Vallejo-Vaz AJ, et al. Circulation. 2017 Nov 14;136(20):1878-1891. doi: 10.1161/CIRCULATIONAHA.117.027966. Epub 2017 Sep 6. Circulation. 2017. PMID: 28877913 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

369 results

Results by year